Status:
UNKNOWN
Cambridge 7 Tesla Cerebral Small Vessel Disease Study
Lead Sponsor:
University of Cambridge
Collaborating Sponsors:
Cambridge University Hospitals NHS Foundation Trust
Wolfson Brain Imaging Centre
Conditions:
Cerebral Small Vessel Diseases
Cerebral Small Vessel Ischemic Disease
Eligibility:
All Genders
18-99 years
Brief Summary
CamSVD is jointly sponsored by the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. We aim to explore and understand the underlying arterial pathology in Cerebral Smal...
Eligibility Criteria
Inclusion
- 1\. Symptomatic lacunar stroke with corresponding lacunar infarct on MRI
Exclusion
- Unable/unwilling to consent;
- Age\<18;
- Stroke aetiology due to cardio-embolism or large vessel disease;
- Lacunar infarcts \>1.5cm;
- Severe stroke (NIHSS score ≥16);
- Evidence of cortical infarct of any size;
- Other major neurological diseases;
- Severe systemic diseases such as heart failure, liver failure and kidney failure or any illness in the judgement of the investigator that could affect participation in the study;
- MRI contraindications e.g. metal objects in or on the body, claustrophobia, pregnancy, known allergy to gadolinium containing contrast agent, impaired renal function with estimated glomerular filtration rate (eGFR) \<59ml/min/1.73m2.
Key Trial Info
Start Date :
March 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 12 2024
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04330222
Start Date
March 9 2020
End Date
January 12 2024
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cambridge
Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ